BAKER COREY 4
4 · Vita Coco Company, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) CFO Corey Baker Sells 4,000 Shares
What Happened
Corey Baker, Chief Financial Officer of Vita Coco Company, sold a total of 4,000 shares of COCO common stock in two open-market transactions, generating combined proceeds of approximately $233,680. The sales were executed at $58.86 (2,000 shares) and $57.98 (2,000 shares). These were sales (not purchases) and were reported as being made pursuant to a Rule 10b5-1 trading plan.
Key Details
- Transactions:
- 2026-03-13: Sold 2,000 shares at $58.86 — proceeds $117,720.
- 2026-03-16: Sold 2,000 shares at $57.98 — proceeds $115,960.
- Total shares sold: 4,000; total proceeds: $233,680.
- Reported as effected under a Rule 10b5-1 trading plan (Footnote F1).
- The filing included additional footnotes (F2–F5) describing various stock-option vesting schedules for the reporting person.
- Shares owned after the transactions: not specified in the provided filing summary.
- Filing timeliness: Form 4 filed 2026-03-17; transactions occurred 2026-03-13 and 2026-03-16 — filing appears timely.
Context
Sales under a 10b5-1 plan are pre-arranged and typically indicate scheduled disposition rather than a discretionary, real-time decision by the insider. Sales are generally considered routine disclosures; they do not necessarily reflect the insider’s view of the company’s near-term prospects.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-13$58.86/sh−2,000$117,720→ 33,951 total - Sale
Common Stock
[F1]2026-03-16$57.98/sh−2,000$115,960→ 31,951 total
- 9,205
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $16.91Exp: 2033-03-10→ Common Stock (9,205 underlying) - 13,481
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $24.35Exp: 2033-05-10→ Common Stock (13,481 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 11,547
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $27.59Exp: 2033-08-07→ Common Stock (11,547 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (5)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F3]The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
- [F4]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F5]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.